DOCSLIB.ORG

A Newsletter for Contributors to the ACS Cycle of Excellence Volume 2 / Issue 2 / Fall 2008

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
A Newsletter for Contributors to the ACS Cycle of Excellence Volume 2 / Issue 2 / Fall 2008 www.acs.org A Newsletter for Contributors to the ACS Cycle of Excellence Volume 2 / Issue 2 / Fall 2008 In This Issue: • Announcing ACS Applied Materials and Interfaces • Introducing JACS Beta & JACS Select • 2007 Journal Citation Reports® by Thomson Reuters • ACS Legacy Archives—A Perfect 80! • Organic Letters Celebrates 10 Years • Gordon G. Hammes Lectureship • ACS Introduces Global Challenges/Chemistry Solutions • A New Delivery Platform for ACS Publications And more... A Supplement to ACS Publications EXCELLENCE VOL. 2 - ISSUE 2 - FALL 2008 b A Message from ACS Publications Our most sincere appreciation to you for your continued support in contributing to the journals of the American Chemical Society. We are reminded of your commitment to excellence with every manuscript we publish. That commitment is reinforced and reaffirmed every summer with the announcement of the annual Journal Citation Reports® by Thomson Reuters. Led by the Journal of the American Chemical Society with its 295, 465 total citations and its rise in ISI Impact Factor® to 7.885, ACS journals once again ranked at #1 in ISI Impact Factor and/or total citations in 15 separate subject categories (see pages 11 & 12). Further to these results, we extend our gratitude around the world as just like the global community of competitors on the world’s stage in this summer’s 2008 Beijing Olympics, so are you a global community of researchers contributing your very best in the publication of your research findings. In support of our global community we continue to grow our editorial presence and support worldwide with centralized support for international offices (see page 18) and recent delegations to China and Taiwan (see pages 6, 7, & 8). On the cover: Also in this issue and in support of the global community is an introduction to the Global Molecular Pharmaceutics Innovations Imperatives (see page 10). The Gii is a collaborative initiative between the From the Feature Topic Issue: ACS and the Society of Chemical Industry targeted to speed innovation, share chemical Natural Products and Production Systems technologies, and determine strategies for effective delivery on a global scale to address the (Volume 5, Issue 2, Guest Editor: Blaine Pfeifer) many significant issues facing our world. The cover illustration highlights the natural We are also very excited to introduce our newest entry to the ACS Cycle of Excellence, environments responsible for natural products, ACS Applied Materials and Interfaces, beginning publication online and in print in early the native or heterologous microbial organisms used to produce natural products, and the 2009 (see page 2 at right), as well as a new delivery platform for ACS Publications coming this final natural products isolated. Photos from fall (see pages 15 & 16). jupiterimages. Microbe images from CDC. Best regards, and as always thank you for your contributions to the ACS Cycle of Excellence. Molecular Pharmaceutics recorded its first We hope you find this newsletter to be useful and recommend that you visit the Excellence ISI Impact Factor® of 11.030 with the recently website for more information at http://pubs.acs.org/4authors/excellence/index.html. announced 2007 Journal Citation Reports® by Thomson Reuters. 11.030 ranks the journal as Best Regards, the highest impact primary research journal in Sean Abell, Editor, Excellence the category of Pharmacology and Pharmacy (205 total journals), and also ranks Molecular Pharmaceutics as the 3rd highest in impact factor among all ACS journals behind Chemical Reviews at 22.757, and Accounts of [email protected] Chemical Research at 16.214, the two highest impact factor journals in all of chemistry. 01 b Announcing ACS Applied Materials and Interfaces—Get to know ACS Applied Materials & Interfaces with Editor-in-Chief Kirk S. Schanze Dr. Schanze, Professor of Chemistry at Excellence: Who should read this new publication? the University of Florida, has recently been selected as the founding editor of The readership will consist of practicing scientists, engineers and ACS Applied Materials & Interfaces, the students working in the area of applied materials science and newest journal from ACS Publications engineering who have an interest in applications of molecular- available in early 2009. Professor Schanze based materials and interfaces. We anticipate that the journal answered our questions about the new will be of interest to the community of materials scientists and journal and provided information about engineers in industrial, academic, and government lab settings, upcoming submission deadlines and where applications guide the development of advanced materials Editor-in-Chief: Kirk S. Schanze, publication dates. that are used in new products and technologies. University of Florida Excellence: Have you already appointed an Editorial Excellence: What are your scientific interests? Advisory Board? My scientific interests are in the area of optical properties of The full Editorial Advisory Board has not yet been appointed, organic and organic/inorganic hybrid materials. My group has but I plan that the EAB will feature a broad and diverse group of an active research program that is focused on the study of scientists from around the world who are working in academia, fluorescent conjugated polymers and luminescent organometallic government and industry labs. Their expertise will cover the conjugated materials. The group is also keenly interested in diverse areas of the journal including applications of organic, the applications of photoactive materials, and we have been inorganic and hybrid materials, biomaterials, polymers, and involved in the development of chemo- and biosensor technology, interfaces. luminescence imaging materials and methods, light emitting diodes and solar cells. Excellence: What types of content do you plan to feature and how soon will researchers be able to submit manuscripts for Excellence: Can you tell our readers about the scope of ACS consideration in the journal? When do you expect to publish Applied Materials & Interfaces? What topics do you plan to the first issue? cover and how does this journal fit into the existing suite of ACS journals? ACS Applied Materials & Interfaces will feature content in several different formats including letters, articles, comments, and invited Coverage will include applications of active and passive electronic/ forum articles and spotlights. Forums will be collections of 5 – 8 optical materials, coatings, colloids, biomaterials and biointerfaces, invited manuscripts published in a single issue that focus on topics polymer materials, hybrid and composite materials, and friction of keen current interest to the journal’s readership. Spotlights will and wear. While this is my initial vision for ACS Applied Materials be articles written by leading scientists and engineers in the field & Interfaces, I anticipate that in the long run the specific content of applied materials science. They will highlight a particular topic of the journal will be driven by the community of active scientists of interest to the readership of the journal, with an emphasis on and engineers who participate as readers, authors and reviewers. the author’s area of expertise. The journal will be the first among ACS materials chemistry Authors will be able to submit their works when online publications to focus primarily on applied science and submission goes live for the journal in mid-August via ACS engineering, as opposed to fundamental science. It will Paragon Plus. We plan to publish our first ASAP articles near the complement the coverage of the existing ACS materials journals end of this year. The first issue of the journal will be available in that are focused on fundamental science including Langmuir, early 2009. Chemistry of Materials, Biomacromolecules, Macromolecules and The Journal of Physical Chemistry B and C. You can find more information about ACS Applied Materials & Interfaces by visiting the website at http://pubs.acs.org/acsami. If you have questions about manuscript submission, you may contact the editorial office at [email protected]. 02 EXCELLENCE NEWSLETTER - VOL. 2 - ISSUE 2 b Introducing JACS Beta and JACS Select Synthesis of Biologically Active Natural independent feedback from the readership Products” with Guest Editor William R. – really a strong positive reception to this Roush, Associate Editor of JACS. The entry particular area of research. So we decided to below is a modified excerpt from a podcast move forward with it as the first thematic Earlier this year, ACS Publications interview with Dr. Roush that is currently issue. introduced JACS Beta, a new website posted on the JACS Beta website. that presents, encourages, and facilitates ACS: How were the articles and innovations and new approaches to the ACS: To begin with, why is JACS doing a communications selected to be featured in presentation of chemical and related virtual issue of the journal? the virtual issue? research to further communication and understanding as emerging fields and Well, as you know, JACS strives to publish With help provided by ACS Publications, the very best work in all fields of chemistry. we did a very detailed, if you will, statistical And there’s a sense among the readers, analysis of papers looking at the numbers of there’s a sense among the editors and the reads, downloads, etc., off of the Web. And editorial advisory board, that as the research we prioritized by this element of readership. is becoming more and more complex, even At least, that was one of the things we looked within the traditional sub-boundaries at. Obviously, given that we picked papers of the field – and especially given the that were published in ’07 and initially in amount of research ongoing, which is now 2008, it’s not possible for the papers in 2008 interdisciplinary, bordering on materials necessarily to have had the same number science, on the biological fields, and so on – of downloads as a paper that appeared, let’s that it’s just becoming a very, very hard task say, in January of ‘07.
Load more

Recommended publications
  • Pharmaceutics (PCEU) 1
    Pharmaceutics (PCEU) 1 PCEU 615. Applied Pharmacokinetics. 2.5 Hours. PHARMACEUTICS (PCEU) Semester course; 2.5 lecture hours. 2.5 credits. Extends the concepts of pharmacokinetics as applied to dosage regimen design, pharmacokinetic PCEU 501. Pharmaceutical Calculations. 1 Hour. variability, drug interactions and statistical strategies for individualization Semester course; 1 lecture hour. 1 credit. This course is designed in a of drug therapy. Lectures and conferences take place throughout the student-centered learning format that supports self-directed learning. The semester. course will help students develop the skill set needed to screen out the PCEU 621. Advanced Pharmaceutics and Drug Disposition. 3 Hours. distractors from the determinant variables in a statement problem and Semester course; 3 lecture hours. 3 credits. Study at the advanced guide their thought processes in sequential use of information to solve level of the relationships between the physiochemical properties of a calculation problems seen in pharmacy practice. drug and dosage form and the absorption, distribution, elimination and PCEU 507. Pharmaceutics and Biopharmaceutics I. 3 Hours. pharmacological effects of the drug. Current theory and methodology Semester course; 3 lecture hours. 3 credits. Designed to describe involved in solving problems at the research level are emphasized. the physico-chemical and biopharmaceutical principles fundamental PCEU 622. Clinical Pharmacokinetics. 3 Hours. to the development of pharmaceutical dosage forms. Topics will Semester course; 2 lecture and 2 laboratory hours. 3 credits. The include pharmaceutical calculations, solid-state properties, solubility, application of current pharmacokinetic theory to clinical problems partitioning, solution properties, disperse systems, micromeritics, involved in optimizing and monitoring drug use in patients.
    [Show full text]
  • Accelerating the Translation of Nanomaterials in Biomedicine
    Accelerating the Translation of Nanomaterials in Biomedicine The MIT Faculty has made this article openly available. Please share how this access benefits you. Your story matters. Citation Mitragotri, Samir; Anderson, Daniel G.; Chen, Xiaoyuan; Chow, Edward K.; Ho, Dean; Kabanov, Alexander V.; Karp, Jeffrey M. et al. “Accelerating the Translation of Nanomaterials in Biomedicine.” ACS Nano 9, no. 7 (July 2015): 6644–6654. © 2015 American Chemical Society As Published http://dx.doi.org/10.1021/acsnano.5b03569 Publisher American Chemical Society (ACS) Version Author's final manuscript Citable link http://hdl.handle.net/1721.1/108653 Terms of Use Article is made available in accordance with the publisher's policy and may be subject to US copyright law. Please refer to the publisher's site for terms of use. HHS Public Access Author manuscript Author ManuscriptAuthor Manuscript Author ACS Nano Manuscript Author . Author manuscript; Manuscript Author available in PMC 2017 January 12. Published in final edited form as: ACS Nano. 2015 July 28; 9(7): 6644–6654. doi:10.1021/acsnano.5b03569. Accelerating the Translation of Nanomaterials in Biomedicine Samir Mitragotri†,*, Daniel G. Anderson‡, Xiaoyuan Chen§, Edward K. Chow||, Dean Ho⊥, Alexander V. Kabanov#, Jeffrey M. Karp¶, Kazunori Kataoka□, Chad A. Mirkin■, Sarah Hurst Petrosko■, Jinjun Shi○, Molly M. Stevens●, Shouheng Sun△, Sweehin Teoh▽, Subbu S. Venkatraman▲, Younan Xia▼, Shutao Wang , Zhen Gu⬢,††,‡‡,*, and Chenjie Xu▽,* †Center for Bioengineering, Department of Chemical Engineering, University
    [Show full text]
  • Nanoplatforms for Imaging, Targeting, and Image-Guided Drug Delivery
    LXIV JCET LECTURE, 25.05.2015, 9.00 Nanoplatforms for Imaging, Targeting, and Image-Guided Drug Delivery Prof. Weibo Cai The Molecular Imaging and Nanotechnology Laboratory Departments of Radiology and Medical Physics School of Medicine and Public Health University of Wisconsin – Madison, USA 1111 Highland Ave, Room 7137 Madison, WI 53705-2275 Tel: (608) 262-1749 Fax: (608) 265-0614 Email: [email protected] OR [email protected] Group website: http://mi.wisc.edu The Molecular Imaging and Nanotechnology Laboratory at the University of Wisconsin - Madison (http://mi.wisc.edu/) is mainly focused on three areas: 1) development of multimodality molecular imaging agents; 2) nanotechnology and its biomedical applications; and 3) molecular therapy of cancer. In this talk, I will present our recent work on molecular imaging and image-guided drug delivery of cancer and some cardiovascular diseases with peptides, proteins, and a variety of nanomaterials. The primary imaging techniques used in these studies are positron emission tomography (PET), photoacoustic tomography (PAT), optical imaging, and magnetic resonance imaging (MRI). Three of the major molecular targets that we are investigating are CD105 (i.e. endoglin), VEGFR, and integrin αvβ3. The nanomaterials that will be discussed in this presentation include nano-graphene oxide, zinc oxide nanomaterials, micelles, silica-based nanoparticles, magnetic nanoparticles, among many others. A few representative side projects will also be presented, such as the facile synthesis of PET/MRI and PET/PAT dual-modality agents. CURRICULUM VITAE Dr. Weibo Cai is an Associate Professor of Radiology and Medical Physics (with Tenure) at the University of Wisconsin - Madison. He received his Ph.D.
    [Show full text]
  • Guidelines for Authors (Revised January 2010)
    Guidelines for Authors (Revised January 2010) Contents (click on the topic) Objectives – Articles – Brief Articles – Current Reviews – Communications | Editorial Organization | Preparation of Electronic Manuscripts | Assembly of Manuscripts – Author Checklist – Title Page – Table of Contents Graphic – Abstract – Keywords – Abbreviations – Introduction – Experimental Section – Results – Discussion – Acknowledgment – Supporting Information – References – Tables – Figure Captions – Illustrations: Figures, Schemes, etc. – Nomenclature – Software – Coordinate Deposition | Submission – Copyright | Publication – Proofs – “Just Accepted” Manuscripts – ASAP Publication – ACS Policies for E-prints and Reprints Objectives The purpose of Molecular Pharmaceutics is to publish the results of original research that contributes significantly to the molecular mechanistic understanding of drug delivery and drug delivery systems. The journal encourages contributions describing research at the interface of drug discovery and drug development. Scientific areas within the scope of the journal include physical and pharmaceutical chemistry, biochemistry and biophysics, molecular and cellular biology, and polymer and materials science as they relate to drug and drug delivery system efficacy. Theoretical and experimental peer-reviewed communications, full-length research papers, brief articles, and critical reviews are welcomed. Submission of a manuscript to Molecular Pharmaceutics implies that the same work has not been previously published, including as part
    [Show full text]
  • 2017 Catalog 2017 Catalog
    2017CATALOG ABOUT ACS AMERICAN CHEMICAL SOCIETY With more than 157,000 members, the American Chemical Society (ACS) Table of Contents>>> is the world’s largest scientific society and one of the world’s leading sources of authoritative scientific information. A nonprofit organization chartered by Congress, ACS is at the forefront of the evolving About ACS Publications ................................................................................. 3 worldwide chemical enterprise and the premier professional home for chemists, chemical Editorial Excellence for 138 years ..............................................................................................................4 What Fuels ACS Publications’ Growth ......................................................................................................6 engineers, and related professionals around the globe. ACS Publications’ Unsurpassed Performance .........................................................................................8 ACS Publications’ Impact on Chemistry ................................................................................................ 10 Select Highlights from ACS Journals ...................................................................................................... 12 An Inspiring Online Platform ................................................................................................................... 14 ACS on Campus ..........................................................................................................................................
    [Show full text]
  • Recent Advances in Nanocarrier-Assisted Therapeutics Delivery Systems
    pharmaceutics Review Recent Advances in Nanocarrier-Assisted Therapeutics Delivery Systems Shi Su and Peter M. Kang * Cardiovascular Institute, Beth Israel Deaconess Medical Center and Harvard Medical School, 3 Blackfan Circle, CLS 910, Boston, MA 02215, USA; [email protected] * Correspondence: [email protected]; Tel.: +1-617-735-4290; Fax: +1-617-735-4207 Received: 30 June 2020; Accepted: 28 August 2020; Published: 1 September 2020 Abstract: Nanotechnologies have attracted increasing attention in their application in medicine, especially in the development of new drug delivery systems. With the help of nano-sized carriers, drugs can reach specific diseased areas, prolonging therapeutic efficacy while decreasing undesired side-effects. In addition, recent nanotechnological advances, such as surface stabilization and stimuli-responsive functionalization have also significantly improved the targeting capacity and therapeutic efficacy of the nanocarrier assisted drug delivery system. In this review, we evaluate recent advances in the development of different nanocarriers and their applications in therapeutics delivery. Keywords: nanomedicine; nanocarriers; drug delivery 1. Introduction Nanotechnology has emerged to be an area of active investigation, especially in its applications in medicine [1]. The nanoscale manipulation allows optimal targeting and delivery as well as the controllable release of drugs or imaging agents [2]. Among all the applications of nanotechnology in medicine, nanocarrier assisted drug delivery system has attracted significant research interest due to its great translational value. The small size of the nanocarriers can help drugs overcome certain biological barriers to reach diseased areas [3,4]. Taking advantage of different nano-sized materials and various structures, nanocarriers can help poorly soluble drugs become more bioavailable and protect easily degraded therapeutics from degradation [5,6].
    [Show full text]
  • (FMIPA) DAN TEKNIK KIMIA ( FTI) ACS E-Journals
    DAFTAR JURNAL INTERNASIONAL UNTUK : PROGRAM STUDI KIMIA (FMIPA) DAN TEKNIK KIMIA ( FTI) ACS E-Journals Publisher: American Chemical Society ACS Publication 1155 Sixteenth Street N.W. Washinton, DC 20036 Number of title: 55 journals Subject : Chemical : Kimia Terms & Conditions: 1. Subscription period is Calendar Year (01 Jan 2019 – 31 Dec 2019). 2. Access full text joumal from 1996 to current issue. No Judul p-ISSN e-ISSN Penerbit 1 Accounts of Chemical Research 0001-4842 1520-4898 ACS Publication 1155 Sixteenth Street N.W. Washinton, DC 20036 2 ACS Applied Materials & Interfaces 1944-8244 1944-8252 ACS Publication 1155 Sixteenth Street N.W. Washinton, DC 20036 3 ACS Biomaterials Science & Engineering 2373-9878 ACS Publication 1155 Sixteenth Street N.W. Washinton, DC 20038 4 ACS Catalysis 2155-5435 ACS Publication 1155 Sixteenth Street N.W. Washinton, DC 20039 5 ACS Central Science 2374-7951 ACS Publication 1155 Sixteenth Street N.W. Washinton, DC 20040 6 ACS Chemical Biology 1554-8929 1554-8937 ACS Publication 1155 Sixteenth Street N.W. Washinton, DC 20041 7 ACS Chemical Neuroscience 1948-7193 ACS Publication 1155 Sixteenth Street N.W. Washinton, DC 20042 8 ACS Combinatorial Science 2156-8952 2156-8944 ACS Publication 1155 Sixteenth Street N.W. Washinton, DC 20043 9 ACS Energy Letters - New in 2016 2380-8195 ACS Publication 1155 Sixteenth Street N.W. Washinton, DC 20044 10 ACS Infectious Diseases 2373-8227 ACS Publication 1155 Sixteenth Street N.W. Washinton, DC 20045 11 ACS Macro Letters 2161-1653 ACS Publication 1155 Sixteenth Street N.W. Washinton, DC 20046 12 ACS Medicinal Chemistry Letters 1948-5875 ACS Publication 1155 Sixteenth Street N.W.
    [Show full text]
  • Graduate Degrees in Pharmaceutical and Biomedical Sciences
    APPLYING TO PHARMACEUTICAL & BIOMEDICAL SCIENCES: Information and Master of Science Degree: Contact Info Graduate Degrees in • Applicants to the PBS Master’s Program must submit a complete application via the Pharmaceutical and UGA Graduate School’s website: grad.uga. Program information and the edu application can be accessed online at Biomedical Sciences • Additionally, prospective students must rx.uga.edu/departments/academic/ identify a PBS faculty member to serve as a pharmaceutical-biomedical-sciences/ major professor prior to admission. Students should contact faculty members directly Questions also may be directed to inquire and notify the PBS graduate admissions office when a faculty mentor is to the Graduate Coordinator and identified. Graduate Program Specialist at [email protected] Doctor of Philosophy Degree: • Applicant to the PBS PhD program must submit a complete application through the Follow us on social media: UGA Graduate School, via the Integrated Life Sciences program. Instructions for submitting your application can be found at @UGACOPPBS their website: www.ils.uga.edu • The application deadline is December 1, and admission through ILS is only available for @UGA_COP_PBS fall semester admittance. • It is also possible, but less common, for PhD applicants to be admitted directly into the @pharmdawgs program with a pre-selected and confirmed faculty advisor. Direct admit PhD student do not perform rotations. Welcome to the University of Georgia College of • Competitive stipend available. Pharmacy and the Department of Pharmaceutical and Biomedical Sciences! We are delighted with your interest in our graduate programs, which College of Pharmacy include a Master of Sciences (M.S.) as well as a Doctor of Philosophy The University of Georgia is accredited by the Commission on Colleges of the Southern 250 W.
    [Show full text]
  • Gus R. Rosania, Ph.D
    Gus R. Rosania, Ph.D. Current work address: Department of Pharmaceutical Sciences University of Michigan 428 Church Street, Rm.3062 Ann Arbor, MI 48109 e-mail: [email protected] cell:734-358-5661 Current home address: 6052 Quebec Avenue Ann Arbor, MI 48103 Education: 1990-1996 Ph.D. Harvard University, Cambridge MA. (Cell and Developmental Biology; advisor: Dr. Joel A. Swanson 1986-1989 B.S. Biological Sciences, Stanford University, Stanford CA. 1986 High School and Bachillerato diplomas, Colegio Karl C. Parrish, Barranquilla, Colombia 1985 Cornell University Summer Program for High School Students, Ithaca, NY 1984 Mathematical Modeling Training Program, Georgetown University, Washington D.C. Professional Positions 2008- Associate Professor, Dept of Pharmaceutical Sciences, Univ of Michigan, Ann Arbor, MI 2003- Member, University of Michigan Comprehensive Cancer Center 2001-2008 Assistant Professor, Dept. of Pharmaceutical Sciences, Univ of Michigan, Ann Arbor,MI 1999-2001 Scientist, Cellomics, Inc., Pittsburgh, PA. 1997-1999 Research Associate, Howard Hughes Medical Institute, (Dept of Chemistry, University of California, Berkeley, CA; advisor: Dr. Peter G. Schultz) 1990-1996 Research Assistant, Harvard University, Cambridge, MA 1996 Teaching Fellow, Harvard University, Cambridge, MA 1995 Teaching Fellow, Harvard University, Cambridge, MA 1993 Teaching Fellow, Harvard University, Cambridge, MA 1989 Laboratory technician, New York Medical College, Valhalla, NY 1989 Teaching Assistant, Hopkins Marine Station, Pacific Grove, CA Significant
    [Show full text]
  • Catalog 2018 Catalog
    1 CATALOG 2018 ACS PUBLICATIONS 2018 CATALOG About ACS Publications ..................................................................3 Editorial Excellence for 138 years ..............................................................................................4 What Fuels ACS Publications’ Growth ....................................................................................6 ACS Publications’ Unsurpassed Performance ......................................................................8 ACS Publications’ Impact on Chemistry ............................................................................... 10 Select Highlights from ACS Journals ......................................................................................12 An Inspiring Online Platform .................................................................................................... 14 ACS on Campus .............................................................................................................................AMERICAN18 CHEMICAL SOCIETY ABOUT ACS Table of Contents ACS Open Access WithOptions more ............................................................ than 157,000 members, the American23 Chemical Society (ACS) More Flavors of Openis Access the world’s .................................................................................................. largest scientific society and one24 of the world’s leading sources Who Benefits from ACS Open Access? ................................................................................25 of
    [Show full text]
  • International Journal of Pharmaceutics
    INTERNATIONAL JOURNAL OF PHARMACEUTICS AUTHOR INFORMATION PACK TABLE OF CONTENTS XXX . • Description p.1 • Audience p.2 • Impact Factor p.2 • Abstracting and Indexing p.2 • Editorial Board p.2 • Guide for Authors p.5 ISSN: 0378-5173 DESCRIPTION . The International Journal of Pharmaceutics has an open access mirror journal International Journal of Pharmaceutics: X which has the same aims and scope and peer-review process. To submit to International Journal of Pharmaceutics: X visit https://www.editorialmanager.com/IJPHARMX/default.aspx. The International Journal of Pharmaceutics is the second most cited journal in the "Pharmacy & Pharmacology" category out of 358 journals, being the true home for pharmaceutical scientists concerned with the physical, chemical and biological properties of devices and delivery systems for drugs, vaccines and biologicals, including their design, manufacture and evaluation. This includes evaluation of the properties of drugs, excipients such as surfactants and polymers and novel materials. The journal has special sections on pharmaceutical nanotechnology and personalized medicines, and publishes research papers, reviews, commentaries and letters to the editor as well as special issues. Editorial Policy The over-riding criteria for publication are originality, high scientific quality and interest to a multidisciplinary audience. Papers not sufficiently substantiated by experimental detail will not be published. Any technical queries will be referred back to the author, although the Editors reserve the right to make alterations in the text without altering the technical content. Manuscripts submitted under multiple authorship are reviewed on the assumption that all listed authors concur with the submission and that a copy of the final manuscript has been approved by all authors and tacitly or explicitly by the responsible authorities in the laboratories where the work was carried out.
    [Show full text]
  • Faculty Research Expertise of the College of Pharmacy at the University of New Mexico Health Sciences Center Vision, Mission & Values Contents
    Pioneers in Research Faculty research expertise of the College of Pharmacy at The University of New Mexico Health Sciences Center Vision, Mission & Values Contents Vision Letters to the Reader To prepare tomorrow’s leaders through innovative teaching, research and clinical 1 practices that translate scientific discoveries into new treatments and models of From the Dean of the UNM College of Pharmacy care to improve both health and quality of life. 2 From the Associate Dean of Research of the UNM College of Pharmacy Mission Featured Articles The mission of the UNM College of Pharmacy is to develop pharmacists, educators and scientists whose leadership, dedication and innovation improve the 3 Creating a Helping Hand health of our local and global communities. Novel vaccines have potential to treat MRSA infections 5 Nutrients, Medicines and Contaminants Values Metals Are Under the Microscope The UNM College of Pharmacy is committed to the following values: 11 Mining Data • Excellence: continuously striving for the highest quality of performance and outcome. Bigger really is better • Integrity: steadfast adherence to moral and ethical principles. 14 It Starts With A Question • Accountability: being held responsible for one’s actions. And leads to better patient care • Collaboration: work in teams to achieve excellence in education, research/scholarship, 20 Nature or Nurture? patient care and service. How Substance Abuse Affects Development • Continuous Learning: strive to acquire knowledge or skills by study, instruction or experience. 22 Novel Ideas Inventors at the UNM College of Pharmacy • Diversity in People and Thinking: embracing inclusiveness, access and equity for all; recognizing and appreciating the totality of the many ways individuals are similar and different in an atmosphere that promotes and celebrates individual and collective achievements.
    [Show full text]